セッション

Contribution of MIR9 on disease progression of chronic myelogenous leukemia

[演者] Ko Sasaki (佐々木 光):1
[著者] Fusako Nagasawa (永澤 英子):1, Kenichi Yoshida (吉田 健一):2, June Takeda (竹田 淳恵):2, Yuichi Shiraishi (白石 友一):3, Kenichi Chiba (千葉 健一):3, Hiroko Tanaka (田中 洋子):3, Ai Okada (岡田 愛):3, Satoru Miyano (宮野 悟):3, Motoshi Ichikawa (市川 幹):1, Seishi Ogawa (小川 誠司):2, Kinuko Mitani (三谷 絹子):1
1:Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan, 2:Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 3:Laboratory of DNA Information Analysis, IMSUT, Tokyo, Japan

Dynamic development of CMV-associated NK cells in Ph+ leukemia patients treated with dasatinib

[演者] Kenichi Ishiyama (石山 賢一):1
[著者] Toshio Kitawaki (北脇 年雄):1, Naoshi Sugimoto (杉本 直志):1,2, Akifumi Takaori-Kondo (高折-近藤 晃史):1, Norimitsu Kadowaki (門脇 則光):3
1:Dept. Hematol./Oncol., Kyoto Univ., Kyoto, Japan, 2:Department of Clinical Application, CiRA, Kyoto University, Kyoto, Japan, 3:Division of Hematology, Kagawa University, Kagawa, Japan

BCR-ABL induces expression of an apoptosis inhibitor Survivin via activation of YAP

[演者] Kenta Moriyama (森山 健太):1
[著者] Konomi Maeda (前田 木実):1, Haruka Oshima (大島 遥香):1, Ryotaro Nishi (西 良太郎):1, Toshiyuki Hori (堀 利行):1
1:Biomedical Sci., Ritsumeikan Univ., Kusatsu, Japan

Enhanced perforin expression associated with dasatinib-induced activation of STATs in NK cells

[演者] Noriyoshi Iriyama (入山 規良):1
[著者] Hiromichi Takahashi (高橋 宏通):1, Katsuhiro Miura (三浦 勝浩):1, Yoshihito Uchino (内野 慶人):1, Masaru Nakagawa (中川 優):1, Yoshihiro Hatta (八田 善弘):1, Masami Takei (武井 正美):1
1:Hematol. Rheumatol., Nihon Univ., Tokyo, Japan

RUNX1 and PHF6 mutations in B lymphoblastic blast phase of CML

[演者] Gabriel C. Caponetti:1
1:Hospital of the University of Pennsylvania, USA

詳細検索